These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 39135916)
1. Low-dose ionizing radiation-induced RET/PTC1 rearrangement via the non-homologous end joining pathway to drive thyroid cancer. Liu Y; Zhu J; Zhou S; Hou Y; Yan Z; Ao X; Wang P; Zhou L; Chen H; Liang X; Guan H; Gao S; Xie D; Gu Y; Zhou PK MedComm (2020); 2024 Aug; 5(8):e690. PubMed ID: 39135916 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of mutagenesis in mammalian cells. Application to human thyroid tumours. Sarasin A; Bounacer A; Lepage F; Schlumberger M; Suarez HG C R Acad Sci III; 1999; 322(2-3):143-9. PubMed ID: 10196666 [TBL] [Abstract][Full Text] [Related]
3. Role of H2O2 in RET/PTC1 chromosomal rearrangement produced by ionizing radiation in human thyroid cells. Ameziane-El-Hassani R; Boufraqech M; Lagente-Chevallier O; Weyemi U; Talbot M; Métivier D; Courtin F; Bidart JM; El Mzibri M; Schlumberger M; Dupuy C Cancer Res; 2010 May; 70(10):4123-32. PubMed ID: 20424115 [TBL] [Abstract][Full Text] [Related]
5. Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTC1 rearrangement or a BRAF mutation to MEK1/2 inhibitors. Henderson YC; Fredrick MJ; Clayman GL Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):810-5. PubMed ID: 17709622 [TBL] [Abstract][Full Text] [Related]
6. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191 [TBL] [Abstract][Full Text] [Related]
7. The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus. Pisarchik AV; Ermak G; Fomicheva V; Kartel NA; Figge J Thyroid; 1998 Feb; 8(2):133-9. PubMed ID: 9510121 [TBL] [Abstract][Full Text] [Related]
8. Temporal trends and clinical correlates for the ret/PTC1 mutation in papillary thyroid carcinoma. Burgess JR; Skabo S; McArdle K; Tucker P ANZ J Surg; 2003; 73(1-2):31-5. PubMed ID: 12534735 [TBL] [Abstract][Full Text] [Related]
9. Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation. Caudill CM; Zhu Z; Ciampi R; Stringer JR; Nikiforov YE J Clin Endocrinol Metab; 2005 Apr; 90(4):2364-9. PubMed ID: 15671095 [TBL] [Abstract][Full Text] [Related]
11. [Dose-Response Dependences for Frequency of RET/PTC Gene Rearrangements in Papillary Thyroid Carcinoma after Irradiation. Simple Pooling Analysis of Molecular Epidemiological Data]. Koterov AN; Ushenkova LN; Biryukov AP Radiats Biol Radioecol; 2016; 56(1):5-25. PubMed ID: 27245001 [TBL] [Abstract][Full Text] [Related]
12. RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma. Romei C; Elisei R Front Endocrinol (Lausanne); 2012; 3():54. PubMed ID: 22654872 [TBL] [Abstract][Full Text] [Related]
13. Effects of silencing the RET/PTC1 oncogene in papillary thyroid carcinoma by siRNA-squalene nanoparticles with and without fusogenic companion GALA-cholesterol. Ali HM; Maksimenko A; Urbinati G; Chapuis H; Raouane M; Desmaële D; Yasuhiro H; Harashima H; Couvreur P; Massaad-Massade L Thyroid; 2014 Feb; 24(2):327-38. PubMed ID: 23885719 [TBL] [Abstract][Full Text] [Related]
14. Opposite modifying effects of HR and NHEJ deficiency on cancer risk in Ptc1 heterozygous mouse cerebellum. Tanori M; Pasquali E; Leonardi S; Giardullo P; Di Majo V; Taccioli G; Essers J; Kanaar R; Mullenders LH; Atkinson MJ; Mancuso M; Saran A; Pazzaglia S Oncogene; 2011 Nov; 30(47):4740-9. PubMed ID: 21602895 [TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of childhood papillary thyroid carcinomas after irradiation: high prevalence of RET rearrangement. Rabes HM; Klugbauer S Recent Results Cancer Res; 1998; 154():248-64. PubMed ID: 10027005 [TBL] [Abstract][Full Text] [Related]
16. [Effect of papillary thyroid carcinoma related gene PTC1 on subcellular localization and function of ATM cell]. Tie Y; Mao JP; Liu B; Song Y; Dong Y; Sun ZX Ai Zheng; 2004 May; 23(5):487-92. PubMed ID: 15142440 [TBL] [Abstract][Full Text] [Related]
17. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes. Klugbauer S; Pfeiffer P; Gassenhuber H; Beimfohr C; Rabes HM Genomics; 2001 Apr; 73(2):149-60. PubMed ID: 11318605 [TBL] [Abstract][Full Text] [Related]
18. Analysis of chromatid-break-repair detects a homologous recombination to non-homologous end-joining switch with increasing load of DNA double-strand breaks. Murmann-Konda T; Soni A; Stuschke M; Iliakis G Mutat Res Genet Toxicol Environ Mutagen; 2021 Jul; 867():503372. PubMed ID: 34266628 [TBL] [Abstract][Full Text] [Related]
19. Sunitinib inhibits MEK/ERK and SAPK/JNK pathways and increases sodium/iodide symporter expression in papillary thyroid cancer. Fenton MS; Marion KM; Salem AK; Hogen R; Naeim F; Hershman JM Thyroid; 2010 Sep; 20(9):965-74. PubMed ID: 20629553 [TBL] [Abstract][Full Text] [Related]
20. [Radiation-induced thyroid carcinomas in children: high prevalence of RET rearrangement]. Rabes HM; Klugbauer S Verh Dtsch Ges Pathol; 1997; 81():139-44. PubMed ID: 9474864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]